Key clinical point: Mandatory testing and treatment for OSA in truckers may be cost effective
Major finding: Truckers treated for OSA saw mean insurance savings of $441 per month in non-OSA–related costs.
Study details: A retrospective cohort study of records from more than 3,000 truckers screened for suspected OSA in a large commercial fleet.
Disclosures: The National Surface Transportation Safety Center for Excellence and Harvard University sponsored the study. Two coauthors disclosed extensive device and pharmaceutical industry funding.
Burks SV et al. Sleep 2019 Oct 24. doi: 10.1093/sleep/zsz262.